- Home
- RMM vs JSPR Comparison
RMM vs JSPR Comparison
Compare RMM & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMM
- JSPR
- Stock Information
- Founded
- RMM 2019
- JSPR 2018
- Country
- RMM United States
- JSPR United States
- Employees
- RMM N/A
- JSPR N/A
- Industry
- RMM Trusts Except Educational Religious and Charitable
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMM Finance
- JSPR Health Care
- Exchange
- RMM Nasdaq
- JSPR Nasdaq
- Market Cap
- RMM 271.2M
- JSPR 85.8M
- IPO Year
- RMM N/A
- JSPR N/A
- Fundamental
- Price
- RMM $13.51
- JSPR $6.82
- Analyst Decision
- RMM
- JSPR Strong Buy
- Analyst Count
- RMM 0
- JSPR 10
- Target Price
- RMM N/A
- JSPR $62.22
- AVG Volume (30 Days)
- RMM 66.5K
- JSPR 369.8K
- Earning Date
- RMM 01-01-0001
- JSPR 08-12-2025
- Dividend Yield
- RMM 7.33%
- JSPR N/A
- EPS Growth
- RMM N/A
- JSPR N/A
- EPS
- RMM 0.96
- JSPR N/A
- Revenue
- RMM N/A
- JSPR N/A
- Revenue This Year
- RMM N/A
- JSPR N/A
- Revenue Next Year
- RMM N/A
- JSPR N/A
- P/E Ratio
- RMM $15.55
- JSPR N/A
- Revenue Growth
- RMM N/A
- JSPR N/A
- 52 Week Low
- RMM $12.32
- JSPR $3.13
- 52 Week High
- RMM $16.10
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- RMM 49.36
- JSPR 72.52
- Support Level
- RMM $13.28
- JSPR $5.35
- Resistance Level
- RMM $13.55
- JSPR $5.72
- Average True Range (ATR)
- RMM 0.11
- JSPR 0.51
- MACD
- RMM 0.02
- JSPR 0.07
- Stochastic Oscillator
- RMM 63.69
- JSPR 97.40
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.